A Neothylline, Lufyllin, diprophylline,Dyphylline CEP of the European Pharmacopoeia monograph is often referred to as a Neothylline, Lufyllin, diprophylline,Dyphylline Certificate of Suitability (COS). The purpose of a Neothylline, Lufyllin, diprophylline,Dyphylline CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Neothylline, Lufyllin, diprophylline,Dyphylline EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Neothylline, Lufyllin, diprophylline,Dyphylline to their clients by showing that a Neothylline, Lufyllin, diprophylline,Dyphylline CEP has been issued for it. The manufacturer submits a Neothylline, Lufyllin, diprophylline,Dyphylline CEP (COS) as part of the market authorization procedure, and it takes on the role of a Neothylline, Lufyllin, diprophylline,Dyphylline CEP holder for the record. Additionally, the data presented in the Neothylline, Lufyllin, diprophylline,Dyphylline CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Neothylline, Lufyllin, diprophylline,Dyphylline DMF.
A Neothylline, Lufyllin, diprophylline,Dyphylline CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Neothylline, Lufyllin, diprophylline,Dyphylline CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Neothylline, Lufyllin, diprophylline,Dyphylline suppliers with CEP (COS) on PharmaCompass.